Autologous Stem Cell Transplantation (ASCT) for Refractory Juvenile-Onset Systemic Sclerosis (jSSc) Is Safe and Well Tolerated and Improves Clinical and Patient-Reported Outcomes
Jessie L. Barnum(Children's Hospital of Pittsburgh), Paul Szabolcs(University of Pittsburgh), Kathryn S. Torok(University of Pittsburgh), Kirsten Rose‐Felker(Children's Hospital of Pittsburgh), Vickie Vandergrift(Children's Hospital of Pittsburgh), F.J. Rosser(University of Pittsburgh), Haley Havrilla(Children's Hospital of Pittsburgh), Nicole Hogue(Children's Hospital of Pittsburgh), Vibha Sood(University of Pittsburgh), S. McIntyre(Children's Hospital of Pittsburgh), Adam C. Olson(Children's Hospital of Pittsburgh)
Cited by 2
Related Papers
Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations
|Journal of Allergy and Clinical Immunology|2018|261
DNA methylation in nasal epithelium, atopy, and atopic asthma in children: a genome-wide study
|The Lancet Respiratory Medicine|2018|208
Type Three Secretion System Island-Encoded Proteins Required for Colonization by Non-O1/Non-O139 Serogroup Vibrio cholerae
|Infection and Immunity|2015|44
High prevalence of gastrointestinal disorders in a large cohort of patients with joint hypermobility
|Journal of Pediatric Gastroenterology and Nutrition|2024|13
A 16-Year-Old Girl with Perianal Skin Tags
|Pediatric Annals|2012|2